These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 5189)

  • 1. Intrinsic resistance to methotrexate of cultured mammalian cells in relation to the inhibition kinetics of their dihydrololate reductases.
    Jackson RC; Hart LI; Harrap KR
    Cancer Res; 1976 Jun; 36(6):1991-7. PubMed ID: 5189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines.
    Li WW; Lin JT; Schweitzer BI; Tong WP; Niedzwiecki D; Bertino JR
    Cancer Res; 1992 Jul; 52(14):3908-13. PubMed ID: 1377601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two different species of dihydrofolate reductase in mammalian cells differentially resistant to amethopterin and methasquin.
    Albrecht AM; Biedler JL; Hutchison DJ
    Cancer Res; 1972 Jul; 32(7):1539-46. PubMed ID: 4402276
    [No Abstract]   [Full Text] [Related]  

  • 10. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    Chen G; Wright JE; Rosowsky A
    Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of antifolate inhibitors of thymidylate and purine synthesis in human soft tissue sarcoma cell lines with intrinsic resistance to methotrexate.
    Li WW; Tong WP; Bertino JR
    Clin Cancer Res; 1995 Jun; 1(6):631-6. PubMed ID: 9816025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
    Fanin R; Banerjee D; Volkenandt M; Waltham M; Li WW; Dicker AP; Schweitzer BI; Bertino JR
    Mol Pharmacol; 1993 Jul; 44(1):13-21. PubMed ID: 8341268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
    Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
    Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.
    Fry DW; Besserer JA; Boritzki TJ
    Cancer Res; 1984 Aug; 44(8):3366-70. PubMed ID: 6547636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
    Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
    Mini E; Moroson BA; Franco CT; Bertino JR
    Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug.
    Pizzorno G; Chang YM; McGuire JJ; Bertino JR
    Cancer Res; 1989 Oct; 49(19):5275-80. PubMed ID: 2475246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pharmacologic rationale for high-dose methotrexate.
    Jolivet J
    NCI Monogr; 1987; (5):61-5. PubMed ID: 2448656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.